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Critical Issue 21: Subcutaneous heparin in acute limb ischemia
There is a need to resolve whether intravenous administration of unfractionated heparin
before treatment can be replaced with subcutaneous unfractionated or low-molecular-
weight heparin in the setting of acute limb ischemia.
Recommendation 56: Vasoactive drugs or sympathectomy in acute limb ischemia
There is no evidence that "vasoactive" drugs or sympathectomy are of benefit in the
treatment of acute limb ischemia.
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C 4.2 Endovascular Procedures for Acute Limb Ischemia
C 4.2.1 Thrombolysis
Formal angiography is performed only in patients in whom the degree of severity allows time
(ie, severity levels I and Ira). In many such patients, depending on other factors (see
Recommendation 57), angiographic findings, catheter-directed thrombolytic therapy is the ini-
tial treatment chosen. The choice depends on location and anatomy of lesions, duration of the
occlusion, the type of clot (embolus vs thrombosis), patient risk (comorbidities), and risk of
procedure (eg, embolectomy under local vs arterial bypass under general anesthesia).
Contraindications to thrombolysis must obviously be observed. However, as a gentler method
of clot removal that potentially may avoid or reduce the scope of open surgery, catheter-directed
thrombolysis is often the initial treatment chosen in levels I and IIa patients. In such instances,
the next step after performing angiography for acute occlusion is to pass a guidewire through
the occluded artery. If the guidewire passes, then intrathrombus lysis should be initiated. If the
catheter fails to pass, regional infusion with the catheter placed proximally may be considered in
an effort to facilitate one subsequent attempt at catheterizing the thrombosed segment.
Regional infusion should not exceed 6 hours before attempting to achieve the optimal catheter
position. Any clinical deterioration during regional infusion should signal the need to discontin-
ue thrombolysis and proceed with surgical revascularization.
Reconunendation 57: Factors for consideration in choosing intervention for acute limb
ischemia
The choice as to which intervention should be used for acute limb ischemia should bebased
on
• location and anatomy of lesion
• duration of acute limb ischemia
• type of clot
• patient-related risks
• surgery-related risks
• contraindications to thrombolysis
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Recommendation 58: Thrombolysis after arterio~aphyin acute limb ischemia.
If the decision is made to proceed with thrombolysis after arteriography, then the
intrathrombus infusion method should be used, which can be performed successfully in
most cases.
Catheter-directed thrombolysis has the theoretical and practical advantages over thromboem-
bolectomy of decreasing endothelial trauma and, in conjunction with angiographic control,
uncovering the underlying lesion(s) and visualizing the runoff vessels.1 Its superiority over intra-
venously administered thrombolytic agents is well established, and the latter should not be used
in ALI. It has been suggested that gradual, low-pressure reperfusion may be advantageous in
preference to the sudden, high-pressure reperfusion associated with surgical revascularization.s-?
Recommendation 59: High-dose systemic thrombolysis in arterial occlusion
Intravenous administration of high doses of currently available thrombolytic agents
should no longer be used for the treatment of arterial occlusion in the leg.
With intraarterial streptokinase, tissue plasminogen activator or urokinase, successful recanaliza-
tion is possible in most carefully selected patients. Furthermore, after successful thrombolysis in
atherosclerotic arteries, the underlying lesion should usually be identified. It then should be cor-
rected by the most appropriate percutaneous or open surgical technique if long-term patency is
to be ach.ieved. 3,4
C 4.2.2 Contraindications to Thrombolysis (Table 34)
C 4.2.3 Other Endovascular Techniques
When thrombolysis indicates underlying localized disease (eg, a discrete, short stenosis), catheter-
based revascularization such as percutaneous transluminal angioplasty (PTA) becomes an attrac-
tive option. Stenoses and occlusions are rarely the sole cause of ALlor even severe chronic symp-
toms but commonly lead to superimposed thrombosis and therefore should be treated to avoid
recurrent thrombosis'ie (see C 4.6, Treatment of the Underlying Lesion, p S159).
Until recently, catheter-directed thrombolysis and open surgical thrombectomy were the only
two basic options for dealing with arterial thromboembolism. Percutaneous aspiration
thrombectomy (PAT) and percutaneous mechanical thrombectomy (PMT) provide an alterna-
tive nonsurgical modality for the treatment of acute limb ischemia.
Table 34. Contraindications to thrombolysis-
Absolute contraindicatitms
1. Established cerebrovascular event (excluding TIA within previous 2 months)
2. Active bleeding diathesis
3. Recent gastrointestinal bleeding (within previous 10 days)
4. Neurosurgery (intracranial, spinal) within previous 3 months
5. Intracranial trauma within previous 3 months
Relative contraindicatitms
1. Cardiopulmonary resuscitation within previous 10 days
2. Major nonvascular surgery or trauma within previous 10 days
3. Uncontrolled hypertension (systolic >180 111m Hg or diastolic >110 mm Hg)
4. Puncture of noncompressible vessel
5. Intracranial tumor
6. Recent eye surgery
Minor contraindication«
1. Hepatic failure, particularly those with coagulopathy
2. Bacterial endocarditis
3. Pregnancy
4. Diabetic hemorrhagic retinopathy
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In high-risk patients, in whom any form of surgery is highly dangerous, it has been suggested
that one of the newer techniques of thrombolysis, such as PMT or PAT, may be safer than
emergency surgery."
Percutaneous aspiration thrombectomy (PAT)
PAT is a technique that uses thin-wall, large-lumen catheters and suction with a 50-mL syringe
to remove embolus or thrombus from native fernoropopliteal arteries, bypass grafts, and run-off
vessels. It has been used together with fibrinolysis to reduce time and dose of the fibrinolytic
agent or as a stand-alone procedure.8,9,10
Percutaneous mechanical thrombectomy (PMT)
Most PMT devices operate on the basis of hydrodynamic recirculation. According to this con-
cept, dissolution of the thrombus occurs within an area of continuous mixing referred to as the
"hydrodynamic vortex." This selectively traps, dissolves, and evacuates the thrombus. Non-recir-
culation devices, which function primarily by direct mechanical thrombus fragmentation, have
been used less frequently for peripheral arterial disease because of the higher risk of peripheral
embolization and higher potential for vascular injury.I I Results from representative studies using
rorationall- and hydraulic recirculation devices 13,14 are listed in Table 35.
Table 35: Patency, limb salvage, and mortality afte r percutaneous mechanical thrombectomy
Patency (%) Limbsalvage (%) Mortality (%)
Device 7. Postopertuive 30iays 30 days 30 days
Rilinger et al,12 1997 Ampl atz 40 9 5 95 0
Reekers et al,13 1996 H ydrolyser 28 9 3 50 89 4
Wagner et al,l4 1997 Angioje t 50 90 76 94 0
The patients entered into these three studies were not identical. For instance, most patients in
the study by Reekers et al13 had acute gr aft occlusion, and the duration of the occlusion was
also longer than in the study by Rilinger et al.12 Most of the patients in the Rilinger et aJI2 and
Wagner et al14 studies had occlusions caused by emboli. Nevertheless, the results were surpris-
ingly similar. In Rilinger et al's study,12 most patients did not need any additional procedures.
By contrast, in the other two studies, approximately 90% of patients required adjunctive catheter
treatments such as an gioplasty, local intraarterial thrombolysis, or atherectomy.l3,14
The efficiency of PMT depends mainly on the age of the thrombus; fresh thrombus responds
better th an older material. Embolic material is not tre ated with a hydraulic device.
Fragmentation devices show better results in embolic occlusions . The limited available clinical
experience suggests that PAT or PMT may be used effectively.ll,12,13,14 They may be used more
safely to replace time-consuming and typically more expensive pharmacological thrombolysis.
Trials comparing PAT or PMT with standard catheter-directed thrombolysis or surgical throm-
boembolectomy are needed to establish their therapeutic role (Critical Issue 21, p SI51 ).
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C4.3
C4.3.1
Surgery
Indications
Immediate surgical revascularization is indicated in the profoundly ischemic limb, that is, class IIb
and early class III (see Figure 17) (see C 2.3, Clinical Classification ofAcute Limb Ischemia, p
5142). Catheter embolectomy is also usuallypreferred for emboli to a nonatherosclerotic limb.
Emboli in nonatherosclerotic limbs usually result in profound ischemia (lIb or III) and therefore are
best treated surgically. In considering operative versus percutaneous revascularization, it must be rec-
ognized that the time from the decision to operate until reperfusion may be substantially longer than
anticipated because of factors outside of the surgeons' control (eg, operating theater availability, anes-
thesia preparation, technical details of the operation).
Recommendation 60: Indications for sw.:gery in acute limb ischemia
Immediately limb-threatening ischemia (class lIb and early class ill) is preferentially
treated surgically.
C 4.3.2 Surgical Technique
Emboli are preferentially removed surgically if they are lodged proximally in the limb or if there is
reason to suspect that they have impacted on a nonatherosclerotic limb. When no further clot can
be retrieved, an angiogram or angioscopy should be performed to visualize distal vessels. In up to
one third of cases, there is residual thrombus, I which, because of the continuing occlusion of the
run-off vessels, can lead to failure.2,3 Some form of intraoperative monitoring of the adequacy of
clot removal is required. The most common of these is "completion" angiography performed
before arteriotomy closure. Fiberoptic endoscopy also has been advocated for this purpose but is
probably inadequate for distal artery visualization.
Distal clot may be treated by intraoperative thrombolysis with instillation of high doses of
thrombolytic agents for a brief period followed by irrigation or additional passages of the bal-
loon catheter. Repeat angiography followed by clinical and Doppler examination of the patient
should be performed on the operating table. This will determine whether the procedure has
been adequate or whether additional attempts at distal clot removal or even bypass are needed.
Percutaneous clot aspiration or thrombolysis, at a later point when the risk of hemorrhage is
reduced, also has been recommended. It is important to continue efforts until there is reason-
able assurance of a viable extremity. As a last resort, isolated limb perfusion technique has been
advocated to reduce the systemic effects of thrombolysis.vf
Unlike embolism, in arterial thrombosis, an underlying local lesion must be sought after clot
